Daisuke ASARI
29Patents
2h-index
13Co-inventors
50Inventor score
Filing activity: Mar 6, 2009 → Apr 12, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9498527B2 | Vaccine composition | Emerging Cross-Sectional Technologies | 5 | Active |
| US9962439B2 | Injectable vaccine composition | Human Necessities | 4 | Active |
| US10071051B2 | WT1 peptide cancer vaccine composition for transdermal administration | Human Necessities | 2 | Active |
| US10071155B2 | Nasal mucosal vaccine composition | Chemistry; Metallurgy | 2 | Active |
| US10076491B2 | Vaccine composition | Human Necessities | 2 | Active |
| US10471141B2 | Bisphosphonate-containing vaccine pharmaceutical composition for humoral immunity | Human Necessities | 1 | Active |
| US10206985B2 | WT1 peptide cancer vaccine composition for mucosal administration | Human Necessities | 1 | Active |
| US10092642B2 | Mucosal vaccine composition | Chemistry; Metallurgy | 1 | Active |
| US8383145B2 | Film-form preparation | Human Necessities | 1 | Active |
| US10925936B2 | Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates | Human Necessities | 1 | Active |
| USD1025284S1 | Gas storage container | General | 1 | Active |
| US10391167B2 | Mucosal vaccine composition | Chemistry; Metallurgy | 1 | Active |
| US9439872B2 | Oral film-form base and preparation | Human Necessities | 1 | Active |
| US10092505B2 | Oral film-form base and preparation | Human Necessities | 1 | Active |
| US10449144B2 | WT1 peptide cancer vaccine composition for transdermal administration | Emerging Cross-Sectional Technologies | 0 | Active |
| US10369219B2 | Composition for enhancing induction of humoral immunity, and vaccine pharmaceutical composition | Emerging Cross-Sectional Technologies | 0 | Active |
| US10195258B2 | Tape preparation of WT1 peptide cancer vaccine for transdermal administration | Emerging Cross-Sectional Technologies | 0 | Active |
| US10286067B2 | Composition for enhancing induction of humoral immunity, and vaccine pharmaceutical composition | General | 0 | Revoked |
| US10688120B2 | Allergy vaccine composition | Human Necessities | 0 | Active |
| US9238004B2 | Oral film-form base and oral film-form preparation | General | 0 | Revoked |
| US10456464B2 | Liquid immunity induction-promoting composition and vaccine pharmaceutical composition that include thrombosis treatment drug | Emerging Cross-Sectional Technologies | 0 | Active |
| US10420837B2 | Vaccine pharmaceutical composition for transdermal administration | Human Necessities | 0 | Active |
| US11278616B2 | Immunity induction promoting composition, and vaccine pharmaceutical composition | Human Necessities | 0 | Active |
| US10471140B2 | Composition for enhancing induction of humoral immunity, and vaccine pharmaceutical composition | Emerging Cross-Sectional Technologies | 0 | Active |
| US10744197B2 | Vaccine pharmaceutical composition for oral administration and method for manufacturing vaccine pharmaceutical composition for oral administration | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.